In this webinar, we'll discuss how mobile apps are changing the healthcare journey for patients and visitors from all walks of life.
Interim results show cancer drug Imbruvica works well with other treatments; two studies show pricey new HCV medications are cost effective; the American College of Physicians wants less cardiac testing
The open-source framework uses the iPhone's apps to gather users' health information.
NICE greenlights Harvoni for Britain's national formulary, Pacira received a CRL instead of an expanded indication and Novo's latest diabetes outreach focuses on patients instead of drug brands.
Millennials and baby boomers have a lot of common: a desire for technology that supports health priorities.
Smartphones drove network traffic.
FDA's latest guidance says it is ok to reduce the amount of risk information in print ads, Google amplifies the health information it will serve up with searches and HBO's John Oliver takes on pharmaceutical marketing.
Genentech Parkinson med encounters preliminary safety issues; Cigna gives Gilead's Harvoni preferred status over AbbVie's Viekira Pak; Valeant proposes $400 million bid to buy bankrupt Dendreon.
Phunware's VP Product Evangelist will explore how hospitals can implement a wayfinding and messaging solution, and how they can expect to benefit from it.
FDA draws fine line between health and wellness apps; Colorado gives biosimilar swap law another look; ZMapp is set to start human trials of its Ebola vaccine.
The snag: identifying what qualifies as download-worthy.
United Healthcare's Baby Blocks app seeks to become all-in-one hub for expectant moms and their babies.
Ackman walks away with $2.5 billion, despite no Allergan deal; Ranbaxy sues FDA over generic Nexium rights; Indian government's Health Ministry recommends breaking BMS cancer drug patent.
A trio of doctors make a case for putting limits on digital promotions, including those in EHRs and through social networks.
Researchers say the iPad app could help assess vision loss.
The Post X-er, Post-Boomer generation considers traditional healthcare "sick care."
Mobile health devices may be more than they appear to be—consumers are taking an open-source approach to getting the monitors they want.
Lightbulb company Royal Philips is swapping its heritage for the consumer healthcare business.
Healthcare workers seek out health-related information on their own time, and through internet connections other than ones offered by their employers.
Novartis explores the virtual care space, a court has dismissed a lawsuit against IPAB, Doctors Without Borders calls the Ebola outbreak "a complete disaster" and Pfizer becomes the first pharma company to pair with the Crohn's and Colitis Foundation of America.
A study indicates consumers stop using them at the six-month mark.
Patients want to do more with mobile and see doctors less. Two studies outline the types of digital interventions patients are interested in.
Recent FDA guidelines for health-tracking apps mean Apple's HealthKit, and similar apps, won't have to jump regulatory hurdles before going live.
The health and lifestyle resource's latest app seeks to provide context for all that biometric data consumers are storing in wearables, wireless scales and glucometers.
The bedside decision-making app includes clinical trial and drug information as well as breaking news.
Texting HCPs may be speedy, but a study finds some built-in risks.
A study by consulting firm Accenture shows that patients not only expect digital outreach, but that their desire to be engaged is consistently being ignored.
@openFDA and its related website launched February 27.
GoQii seeks to convert tracked calories, steps and distance into a philanthropic device.
Survey questions can be uploaded as needed.
Did you miss January's Top 40 Healthcare Transformers issue? Read how these inventors, strategists, entrepreneurs and wonks are challenging, disrupting and otherwise transforming the healthcare business. And join us April 30 to honor them at the Transforming Healthcare Dinner. Click here.
- US pharma market value projected to be $550 billion in five years
- Lawmakers propose allowing pharma companies to share some off-label information
- Biosimilar uptake will require companies to tell a trustworthy backstory
- Everyday Health buys rare-disease agency Cambridge BioMarketing
- Apple's ResearchKit: Five Guidelines for Pharma